Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) Stock Overview

Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

DGX●NYSE
HealthcareMedical - Diagnostics & Research
$244.39
$3.09(1.28%)
U.S. Market opens in 59h 40m

Quest Diagnostics Incorporated (DGX)

Meyka AI Score

Z

Key Financials

Market Cap27B
P/E Ratio25.54
EPS (TTM)$10.14
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$235.40
3 Months$221.28
1 Year Target$201.10

DGX Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Quest Diagnostics Incorporated (NYSE: DGX) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Quest Diagnostics Incorporated's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DGX on the NYSE shows an RSI of 74.26, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $201.10 for the NYSE listing.

Key metrics behind Quest Diagnostics Incorporated's NYSE-traded stock include a P/E ratio of 25.54 and a market capitalization of 27B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DGX on the NYSE.

Price Performance (NYSE: DGX)

1-Day Change
1.26%
5-Day Change
3.61%
1-Month Change
18.13%
3-Month Change
26.07%
6-Month Change
20.72%
Year-to-Date (YTD) Change
40.81%
1-Year Change
33.00%
3-Year Change
83.87%
5-Year Change
62.32%
All-Time (Max) Change
6881.14%

Contact Information

https://www.questdiagnostics.com
973 520 2700
500 Plaza Drive, Secaucus, NJ, 07094

Company Facts

515,000 Employees
IPO DateDec 17, 1996
CountryUS
Actively Trading

Frequently Asked Questions